Treatment of experimental osteonecrosis of the hip in adult rabbits with a single local injection of recombinant human FGF-2 microspheres

Hernigou P, Ooignard A, Nogier A, Manicom O (2004) Fate of very small asymptomatic stage-I osteonecrotic lesions of the hip. J Bone Joint Surg Am 86:2589–2593

Mont MA, Jones LC, Hngerford DS (2006) Nontraumatic osteonecrosis of the femoral head: ten years later. J Bone Joint Surg Am 88:1117–1132

Marker DR, Seylee TM, McGrath MS, Delanois RE, Ulrich SD, Mont MA (2008) Treatment of early stage osteonecrosis of the femoral head. J Bone Joint Surg Am 90:175–187

Mont MA, Jones LC, Einhorn TA, Hungerford DS, Reddi AH (1998) Osteonecrosis of the femoral head: potential treatment with growth and differentiation factors. Clin Orthop Relat Res 355:314–335

Lieberman JR, Conduah A, Urist MR (2004) Treatment of osteonecrosis of the femoral head with core decompression and human bone morphogenetic protein. Clin Orthop Relat Res 429:139–145

Gangji V, Hauzeur JP, Matos C, De Maertelaer V, Toungouz M, Lambermont M (2004) Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells: a pilot study. J Bone Joint Surg Am 86:1153–1160

Hernigou P, Beaujean F (2002) Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res 405:14–23

Desai MM, Sonone S, Bhasme V (2005) Efficacy of alendronate in the treatment of avascular necrosis of the hip. Rheumatology 44:1331–1332

Lai KA, Shen WJ, Yang CY, Shao CJ, Hsu JT, Lin RM (2005) The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. J Bone Joint Surg Am 87:2155–2159

Cui Q, Wang CJ, Su CC, Balian G (1997) Lovastatin prevents steroid induced adipogenesis and osteonecrosis. Clin Orthop Relat Res 344:8–19

Pritchett JW (2001) Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin Orthop Relat Res 386:173–178

Canalis E, Centrella M, McCarthy T (1988) Effects of basic fibroblast growth factor on bone formation in vitro. J Clin Invest 81:1572–1577

Lieberman JR, Daluiski A, Einhorn TA (2002) The role of growth factors in the repair of bone biology and clinical applications. J Bone Joint Surg Am 84:1032–1044

Itoh N, Orniz DM (2004) Evolution of the Fgf and Fgfr gene families. Trends Genet 20:563–569

Kato T, Kawaguchi H, Hanada K, Aoyama Y, Nakamura T, Kuzutani K, Tamura M, Kurokawa T, Nakamura K (1998) Single local injection of recombinant fibroblast growth factor-2 stimulates healing of segmental bone defects in rabbit. J Orthop Res 16:654–659

Nakamura T, Hara Y, Tagawa M, Yuge T, Fukuda H, Nigi H (1998) Recombinant human basic fibroblast growth factor accelerates fracture healing by enhancing callus remodeling in experimental dog tibial fracture. J Bone Miner Res 13:942–949

Chen WJ, Jingushi W, Aoyama I, Anzai J, Hirata G, Tamura M, Iwamoto Y (2004) Effects of FGF-2 on metaphyseal fracture in rabbit tibiae. J Bone Miner Metab 22:303–309

Tabata Y, Nagano A, Ikada Y (1999) Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng 5:127–147

Yamamoto M, Ikeda Y, Tabata Y (2001) Controlled release of growth factors based on biodegradation of gelatin hydrogel. J Biomater Sci Polym Ed 12:77–88

Tabata Y (2003) Tissue regeneration based on growth factor release. Tissue Eng 9(suppl 1):S5–S15

Tabata Y, Yamada K, Miyamoto S, Nagata I, Kikuchi H, Aoyama I, Tamura M, Ikada Y (1998) Bone regeneration by basic fibroblast growth factor complexed with biodegradable hydrogel. Biomaterials 19:807–815

Tabata Y, Hijikata S, Muniruzzaman M, Ikada Y (1999) Neovascularization through biodegradable gelatin microspheres incorporating basic fibroblast growth factor. J Biomater Sci Polym Ed 10:79

Sakakibara Y, Nishimura K, Tambara K, Yamamoto M, Lu F, Tabata Y, Komeda M (2001) Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation. J Thorac Cardiovasc Surg 124:50

Kawaguchi H, Jingushi S, Izumi M, Fukunaga M, Matsushita T, Nakamura T, Mizuno K, Nakamura T, Nakamura K (2007) Local application of recombinant human fibroblast growth factor-2 on bone repair: a dose-escalation prospective trial on patients with osteotomy. J Orthop Res 25:480–487

Tabata Y, Yamada K, Hong L, Miyamoto S, Hashimoto N, Ikada Y (1999) Skull bone regeneration in primates in response to basic fibroblast growth factor. J Neurosurg 91:851

Norman D, Reis D, Zinman G, Misselevich I, Boss JH (1998) Vascular deprivation-induced necrosis of the femoral head of the rat. An experimental model of avascular osteonecrosis in the skeletally immature individual or Legg–Perthes disease. Int J Exp Pathol 79:173–181

Hofstaetter JG, Wang J, Yan J, Glimcher MJ (2009) The effects of allendronate in the treatment of experimental osteonecrosis of the hip on adult rabbits. Osteoarthritis Cartil 17:362–370

Okano K, Enomoto H, Osaki M, Shindo H (2008) Rotational acetabular osteotomy for advanced osteoarthritis secondary to developmental dysplasia of the hip. J Bone Joint Surg Br 90:23–26

Magnussen RA, Guilak F, Vail TP (2005) Articular cartilage degeneration in post-collapse osteonecrosis of the femoral head. Radiographic staging, macroscopic grading, and histologic changes. J Bone Joint Surg Am 87:1272–1277

Ficat RP, Arlet J (1980) Functional investigation of bone under normal conditions. In: Hungerford DS (ed) Ischemia and necrosis of bone. Williams & Wilkins, Baltimore, pp 29–52

Otsu N (1979) A threshold selection method from gray-level histograms. IEEE Trans Syst Man Cybern 9:62–66

Mankin HJ, Dorfman H, Lippiello L, Zarins A (1971) Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 53:523–537

Shida JI, Jingushi S, Izumi T, Ikenoue T, Iwamoto Y (2001) Basic fibroblast growth factor regulates expression of growth factors in rat epiphyseal chondrocytes. J Orthop Res 19:259–264

Kawaguchi H, Pilbeam CC, Gronowicz G, Abreu C, Fletcher BS, Herschman HR, Raisz LG, Hurley MM (1995) Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor. J Clin Invest 96:923–930

Collin-Osdoby P, Rothe L, Bekker S, Anderson F, Huang Y, Osdoby P (2002) Basic fibroblast growth factor stimulates osteoclast recruitment, development, and bone pit resorption in association with angiogenesis in vivo on the chick chorioallantoic membrane and activates isolated avian osteoclast resorption in vitro. J Bone Miner Res 17:1859–1871

Chikazu D, Hakeda Y, Ogata N, Nemoto K, Itabashi A, Takato T, Kumegawa M, Nakamura K, Kawaguchi H (2000) Fibroblast growth factor (FGF)-2 directly stimulates mature osteoclast function through activation of FGF receptor 1 and p42/p44 MAP kinase. J Biol Chem 6:31444–31450

Komaki H, Tanaka T, Chazono M, Kikuchi T (2006) Repair of segmental defects in rabbit tibiae using a complex β-tricalcium phosphate, type I collagen, and fibroblast growth factor-2. Biomaterials 27:5118–5126

Tsurushima H, Marushima A, Suzuki K, Oyane A, Sogo Y, Nakamura K, Matsumura A, Ito A (2010) Enhanced bone formation using hydroxyapatite ceramic coated with fibroblast growth factor-2. Acta Biomater doi: 10.1016/j.actbio.2009.12.045

Hungerford MW, Mont MA (2000) Potential uses of cytokines and growth factors in treatment of osteonecrosis. Orthopade 29:442–448

D’Amore PA, Smith SR (1993) Growth factor effects on cells of the vascular wall: a survey. Growth Factors 8:61–75

Ferrara N, Henzel WJ (1989) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851–858